These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37203394)

  • 41. TWIST1 Promotes Colorectal Carcinoma Stemness and Oxaliplatin Resistance by Activating Microfibrillar-Associated Protein 2.
    Liu Y; Chen M; Wu B
    Assay Drug Dev Technol; 2023 Jul; 21(5):202-211. PubMed ID: 37428562
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FOXM1/DVL2/Snail axis drives metastasis and chemoresistance of colorectal cancer.
    Yang Y; Jiang H; Li W; Chen L; Zhu W; Xian Y; Han Z; Yin L; Liu Y; Wang Y; Pan K; Zhang K
    Aging (Albany NY); 2020 Dec; 12(23):24424-24440. PubMed ID: 33291076
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer.
    Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C
    Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168
    [TBL] [Abstract][Full Text] [Related]  

  • 44. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blocking the Wnt/β‑catenin signaling pathway to treat colorectal cancer: Strategies to improve current therapies (Review).
    Chen Y; Chen M; Deng K
    Int J Oncol; 2023 Feb; 62(2):. PubMed ID: 36579676
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FOXD1-AS1 promotes malignant behaviours of prostate cancer cells via the miR-3167/YWHAZ axis.
    Qu W; Wei X; Zhang H; Hou J
    Andrologia; 2022 Feb; 54(1):e14263. PubMed ID: 34674391
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TNF‑α promotes the malignant transformation of intestinal stem cells through the NF‑κB and Wnt/β‑catenin signaling pathways.
    Zhao X; Ma L; Dai L; Zuo D; Li X; Zhu H; Xu F
    Oncol Rep; 2020 Aug; 44(2):577-588. PubMed ID: 32627006
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Loss of miR-638 in vitro promotes cell invasion and a mesenchymal-like transition by influencing SOX2 expression in colorectal carcinoma cells.
    Ma K; Pan X; Fan P; He Y; Gu J; Wang W; Zhang T; Li Z; Luo X
    Mol Cancer; 2014 May; 13():118. PubMed ID: 24885288
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA‑8063 targets heterogeneous nuclear ribonucleoprotein AB to inhibit the self‑renewal of colorectal cancer stem cells via the Wnt/β‑catenin pathway.
    Chen ZQ; Yuan T; Jiang H; Yang YY; Wang L; Fu RM; Luo SQ; Zhang T; Wu ZY; Wen KM
    Oncol Rep; 2021 Oct; 46(4):. PubMed ID: 34396427
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT/NF-κB pathway in colorectal cancer.
    Chen C; Xu ZQ; Zong YP; Ou BC; Shen XH; Feng H; Zheng MH; Zhao JK; Lu AG
    Cell Death Dis; 2019 Feb; 10(3):178. PubMed ID: 30792394
    [TBL] [Abstract][Full Text] [Related]  

  • 51. miR‑122/SENP1 axis confers stemness and chemoresistance to liver cancer through Wnt/β‑catenin signaling.
    Dai J; Hao Y; Chen X; Yu Q; Wang B
    Oncol Lett; 2023 Sep; 26(3):390. PubMed ID: 37559577
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ubiquitin-Specific Peptidase 22 Contributes to Colorectal Cancer Stemness and Chemoresistance via Wnt/β-Catenin Pathway.
    Jiang S; Song C; Gu X; Wang M; Miao D; Lv J; Liu Y
    Cell Physiol Biochem; 2018; 46(4):1412-1422. PubMed ID: 29689565
    [TBL] [Abstract][Full Text] [Related]  

  • 53. LGR5 regulates survival through mitochondria-mediated apoptosis and by targeting the Wnt/β-catenin signaling pathway in colorectal cancer cells.
    Hsu HC; Liu YS; Tseng KC; Tan BC; Chen SJ; Chen HC
    Cell Signal; 2014 Nov; 26(11):2333-42. PubMed ID: 25025569
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting DCLK1 overcomes 5-fluorouracil resistance in colorectal cancer through inhibiting CCAR1/β-catenin pathway-mediated cancer stemness.
    Wang L; Zhao L; Lin Z; Yu D; Jin M; Zhou P; Ren J; Cheng J; Yang K; Wu G; Zhang T; Zhang D
    Clin Transl Med; 2022 May; 12(5):e743. PubMed ID: 35522902
    [TBL] [Abstract][Full Text] [Related]  

  • 55. LncRNA SLCO4A1-AS1 facilitates growth and metastasis of colorectal cancer through β-catenin-dependent Wnt pathway.
    Yu J; Han Z; Sun Z; Wang Y; Zheng M; Song C
    J Exp Clin Cancer Res; 2018 Sep; 37(1):222. PubMed ID: 30201010
    [TBL] [Abstract][Full Text] [Related]  

  • 56. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
    Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R
    J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TMEM97 is transcriptionally activated by YY1 and promotes colorectal cancer progression via the GSK-3β/β-catenin signaling pathway.
    Mao D; Zhang X; Wang Z; Xu G; Zhang Y
    Hum Cell; 2022 Sep; 35(5):1535-1546. PubMed ID: 35907137
    [TBL] [Abstract][Full Text] [Related]  

  • 58. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
    Ma X; Wang B; Wang X; Luo Y; Fan W
    PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hsa_circ_0026628 promotes the development of colorectal cancer by targeting SP1 to activate the Wnt/β-catenin pathway.
    Zhang X; Yao J; Shi H; Gao B; Zhou H; Zhang Y; Zhao D; Gao S; Wang C; Zhang L
    Cell Death Dis; 2021 Aug; 12(9):802. PubMed ID: 34420031
    [TBL] [Abstract][Full Text] [Related]  

  • 60. miR-133b suppresses colorectal cancer cell stemness and chemoresistance by targeting methyltransferase DOT1L.
    Lv L; Li Q; Chen S; Zhang X; Tao X; Tang X; Wang S; Che G; Yu Y; He L
    Exp Cell Res; 2019 Dec; 385(1):111597. PubMed ID: 31525340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.